Renaissance Technologies - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 65 filers reported holding NEOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$673,000
+32.0%
1,076,683
+12.0%
0.00%0.0%
Q3 2020$510,000
-9.6%
960,900
+16.7%
0.00%
Q2 2020$564,000
+7.2%
823,143
+17.4%
0.00%
-100.0%
Q1 2020$526,000
-47.8%
701,243
+5.2%
0.00%0.0%
Q4 2019$1,007,000
+66.7%
666,868
+63.4%
0.00%0.0%
Q3 2019$604,000
+230.1%
408,162
+188.3%
0.00%
Q2 2019$183,000
-34.4%
141,555
+32.3%
0.00%
Q1 2019$279,000
-54.2%
106,968
+151.7%
0.00%
-100.0%
Q4 2015$609,00042,5000.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
DSC Advisors, L.P. 784,704$5,163,0003.14%
WALL STREET ASSOCIATES 149,343$983,0000.34%
DAFNA Capital Management LLC 38,873$256,0000.18%
Perceptive Advisors 330,593$2,175,0000.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 229,166$1,508,0000.07%
FALCON POINT CAPITAL, LLC 69,135$408,0000.06%
Cormorant Asset Management, LP 50,613$333,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 80,000$526,0000.01%
FRANKLIN RESOURCES INC 1,314,700$8,650,0000.01%
PUTNAM INVESTMENTS LLC 215,000$1,415,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders